Product Information

HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.1351 per EA under NDC 13107001905. Its NADAC has been published 657 times since Nov 28, 2013.

HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET

Hydrocodone Bitartrate and Acetaminophen
$0.1351per EA
DEA Schedule CII

Strength

325; 5 mg/1; mg/1

NDC

13107001905

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA201013

On Market Since

4/11/2012

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.1351 per EA
All-time high$0.1957 (May 13, 2015)
All-time low$0.0764 (Nov 20, 2019)
52-week high$0.1351
52-week low$0.1273
Median price$0.1167
Average price$0.1178
Largest weekly change+35.0% (Dec 17, 2014)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+3.1%

3M

+4.8%

6M

+4.1%

1Y

+2.7%

3Y

+19.8%

5Y

+47.3%

All

-0.3%

Generic Alternatives

The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.1351 per EA (NDC 13107001905), effective Jun 24, 2026.

How has the price of HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has held within roughly two percent of its current level. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

Since Nov 28, 2013, the NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has ranged from a low of $0.0764 (Nov 20, 2019) to a high of $0.1957 (May 13, 2015), with a median of $0.1167 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET, is $0.1066 per EA — about 21% below HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET.

Who manufactures HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET (NDC 13107001905) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.